Cidara Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for Cidara Therapeutics stock have an average target of 32.2, with a low estimate of 24 and a high estimate of 45. The average target predicts an increase of 48.39% from the current stock price of 21.70.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$24	$32.2	$33	$45
Change	+10.60%	+48.39%	+52.07%	+107.37%

* Price targets were last updated on Dec 13, 2024.

Analyst Ratings

The average analyst rating for CDTX stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Aug '24	Sep '24	Oct '24	Nov '24	Dec '24	Jan '25
Strong Buy	3	3	3	4	4	4
Buy	1	1	1	1	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	5	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Gregory Renza RBC Capital	RBC Capital	Buy Initiates $34	Buy	Initiates	$34	+56.68%	Dec 13, 2024
Stephen Brozak WBB Securities	WBB Securities	Strong Buy Maintains $40 → $45	Strong Buy	Maintains	$40 → $45	+107.37%	Dec 5, 2024
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $24	Strong Buy	Reiterates	$24	+10.60%	Nov 11, 2024
Seamus Fernandez Guggenheim	Guggenheim	Strong Buy Initiates $33	Strong Buy	Initiates	$33	+52.07%	Nov 8, 2024
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $24	Strong Buy	Reiterates	$24	+10.60%	Oct 22, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

7.03M

from 23.28M

-69.81%

from 23.28M

Revenue Next Year

n/a

from 7.03M

EPS This Year

-24.92

from -5.25

EPS Next Year

-10.51

from -24.92

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	20.92M	12.07M	49.57M	23.50M	23.28M	7.03M	-	-
Revenue Growth	-	-42.30%	310.81%	-52.60%	-0.91%	-69.81%	-	-
EPS	-27.45	-36.03	-16.20	-9.61	-5.25	-24.92	-10.51	-9.63
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	7	7	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	10.5M	n/a	n/a
Avg	7.0M	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2024	2025	2026
High	-54.9%	-	-
Avg	-69.8%	-	-
Low	-	-	-

EPS Forecast

EPS	2024	2025	2026
High	-19.83	-5.01	-4.75
Avg	-24.92	-10.51	-9.63
Low	-29.37	-16.42	-18.06

EPS Growth

EPS Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.